期刊文献+

胸腹水标本分离菌构成与耐药性 被引量:4

Constitution and their drug resistance of clinical isolated bacteria in hydrothorax-peritoneum samples
下载PDF
导出
摘要 目的探讨胸腹水标本分离菌构成及其耐药性。方法对2004年1月至2005年12月临床送检胸腹水标本细菌培养和药敏试验资料进行回顾性分析。结果(1)1 682例胸腹水标本细菌培养阳性276例,阳性16.4%,检出病原菌327株,以铜绿假单胞菌、金黄色葡萄球菌、表皮葡萄球菌、大肠埃希菌最多见。(2)胸水标本G+球菌与G-杆菌构成比接近,腹水标本G-杆菌占优势(63.5%)。(3)4种主要病原菌对链霉素、庆大霉素、氨苄西林、羧苄西林、克林霉素耐药,亚胺培南、舒普深、美洛西林则显示敏感,其他抗菌药物呈现不同程度的耐药。结论加强腹水标本的细菌学检查,依据药敏试验合理使用抗菌药物,对胸腔感染的诊断与治疗具有重要价值。 Objective To investigate the bacteriological feature and drug-fast of bacteria in hydrothorax-peritoneum. Method The retrospective analysis of bacteria culture and drug-sensitive test in hydrothorax-peritoneum preparation collected from 2004. 1 to 2005.12 was done. Results ( 1 ) The hydrothorax-peritoneum preparation were 1682 cases, the bacteria culture positive were 276 eases ,positive rate was 16.4% ,327 strains pathogenic bacteria were found in which P. aesuginosa ,S. aurus ,S. epidermidis, E. coli were seen most commonly. ( 2 ) The composition of G + coccus and G - bacillus were almost equivalent in hydrothorax. G - baeillus's percentage was high(63.5% ) in hydroperitoneum. (3)Four pathogenic bacteria showed drug-fast to Strcptomyein, Gentamyein, Ampieillin, Carbenieillin, Clindamyein, but sensitive to Imipenem, Sulperazon, Mezlaeillin. The others were drug fast against clinical isolates at different degree. Condusions The bacteriological examination of hydrothorax-peritoneum must be done. Selecting bacteria-sensitive drug has a important value to diagnosing and treating infection of thoracic and abdominal cavity.
出处 《中国微生态学杂志》 CAS CSCD 2007年第2期209-210,共2页 Chinese Journal of Microecology
关键词 胸水 腹水 病原菌 抗菌药物 抗药性 微生物 Hydrothorax Hydroperitoneum Pathogenic bacteria Anti-bacteria drug Drug resistance Microbial
  • 相关文献

参考文献7

二级参考文献33

  • 1朱德妹,汪复,胡付品,吴湜,张婴元.2002年上海地区医院细菌耐药性监测[J].中华传染病杂志,2004,22(3):154-159. 被引量:63
  • 2朱德妹,汪复,张婴元.2003年上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2005,5(1):4-12. 被引量:147
  • 3孙维佳,吕新生.腹腔感染与多脏器功能衰竭[J].腹部外科,1996,9(1):6-10. 被引量:2
  • 4秦俊玲,韩呈武,王素兰,李春英,王路,林桂秋.10年临床感染细菌的病原学与常用抗生素的调查分析[J].中华医院感染学杂志,1996,6(4):243-245. 被引量:59
  • 5[1]Moshe S C, Asher H B, Moshe H M.Current surgical management of severe intraabdominal infection[J]. Surgery,1992,112(3):489.
  • 6[3]Klyachkin M L, Dhillon J S, Kaveh S J, et al. Current management of severe intraabdominal infection[J]. Current Surgery, 1998,55(1):39.
  • 7[6]Jarvis W R, Cayenes R P, Horan T C, et al. Semiannual report: aggregated date from the National Nosocomial Infections Surveillance(NNIC)system[J]. CDC,1996,1.
  • 8[11]Merlino J I, Malangoni M A, Smith C M, et al. Prospective randomized trials affect the outcomes of intraabdominal infection[J]. Ann Surg,2001,233(6):859.
  • 9National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility testing, Fourteenth Informational Supplement[S]. 2004,M100-S14.
  • 10Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial susceptibility testing; Fifteenth Informational Supplement[S]. 2005, M100-S15.

共引文献722

同被引文献29

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部